RALEIGH, N.C.--(BUSINESS WIRE)--INC Research ®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, today announced the appointment of Wayne Whittingham, as vice president, Regulatory Affairs and Strategic Drug Development. In this role, Whittingham is able to leverage his career experiences in federally regulated environments, technical regulatory expertise and project management skills to enhance and expand the capabilities of his team to better serve the overall global development needs of INC Research customers.
